This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

23 Dec 2010

FDA Issues Complete Response Letter for Lower-Volume Glatiramer Acetate sNDA

Teva Pharmaceutical Industries Ltd. announced today that it has received a complete response letter from FDA for its supplemental New Drug Application a lower-volume (0.5mL) injection of glatiramer acetate.

Related News